415-389-4670655 Redwood Highway #395, Mill Valley, California 94941
TwitterFacebookLinkedin
Liviakis Financial Communications Inc.Liviakis Financial Communications Inc.
Liviakis Financial Communications Inc.
Comprehensive Investor Relations Services in partnership with growth companies
  • HOME
  • ABOUT LIVIAKIS
  • SERVICES
  • CORPORATE PORTFOLIO
  • NEWS
    • COMPANY NEWS
    • OUR BLOG
  • CONTACT
Menu back  
COMPANY NEWS
Date Name
DescAsc
COMPANY & BLOG UPDATES
RECENT NEWS
  • CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction July 28, 2020
  • GoldHaven Files for Listing on the OTCQB July 21, 2020
  • Energy Fuels Strengthens Balance Sheet by Eliminating Debt and Growing Uranium Inventories July 20, 2020
  • CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel July 15, 2020
  • CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements July 8, 2020
CONTACT US
Phone: 415-389-4670
Fax: 415-389-4694
655 Redwood Highway #395
 Mill Valley, California 94941

Our privacy policy
COMPANY NEWS
  • CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction
    July 28, 2020
  • GoldHaven Files for Listing on the OTCQB
    July 21, 2020
ABOUT LIVIAKIS
  • Testimonials
  • Press
  • Philanthropy
SITEMAP
  • About Liviakis
  • Services
  • Corporate Portfolio
  • Company News
  • Contact
Liviakis Financial Communications Inc.
©2015 Liviakis Financial | All Rights Reserved

Website Design: Hi 5 Studio | Video Production: Mav Media